Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OrthoPulse 2.0 and 2.1 Product Evaluation and Assessing Clinical Effectiveness: A Feasibility Study

NCT03683017 is registered in ClinicalTrials.gov with Biolux Research Holdings, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OrthoPulse 2.0 and 2.1 Product Evaluation and Assessing Clinical Effectiveness: A Feasibility Study
Lead sponsor
Biolux Research Holdings, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
December 22, 2017
Completion date
June 30, 2020
Enrollment
35 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.